Table 1

Age profile and prevalence of chronic diseases in the Basque Country population
MALE FEMALE MALE FEMALE
Total sample 1,111,047 49.10% 1,151,639 50.90% Rheumatoid arthritis and autoimmune and connective tissue diseases 8,571 0.77% 14,858 1.29%
By age groups Gout 19,072 1.72% 3,719 0.32%
0-17 175,435 15.80% 164,105 14.26% Chromosomal anomalies or Inherited metabolic disorders 12,765 1.15% 9,527 0.83%
18-44 429,365 38.65% 407,960 35.43% Heart failure 10,151 0.91% 11,057 0.96%
45-64 313,689 28.23% 319,435 27.74% Diverticular disease of intestine 8,221 0.74% 11,120 0.97%
65-74 98,916 8.90% 110,762 9.62% Chronic liver or pancreatic disease 11,942 1.07% 6,358 0.55%
75+ 93,642 8.43% 149,377 12.98% Schizophrenia, affective psychosis or bipolar disorder 8,068 0.73% 7,073 0.61%
Parkinson’s disease 5,743 0.52% 6,838 0.59%
Prevalence of chronic disease Viral Hepatitis 7,083 0.64% 4,510 0.39%
Hypertension 207,478 18.67% 223,753 19.43% Paralysis or muscular dystrophy 5,941 0.53% 5,208 0.45%
Anxiety & other neurotic, stress related & somatoform disorders 80,755 7.27% 161,981 14.07% Irritable bowel syndrome 3,298 0.30% 6,298 0.55%
Diabetes Mellitus 70,614 6.36% 60,412 5.25% Alcohol problems 7,037 0.63% 1,887 0.16%
Degenerative joint disease 25,897 2.33% 60,878 5.29% Epilepsy (currently treated) 4,729 0.43% 4,162 0.36%
Treated dyspepsia 33,624 3.03% 53,088 4.61% Inflammatory bowel disease 4,381 0.39% 4,314 0.37%
Depression 19,944 1.80% 59,894 5.20% Peripheral vascular disease 6,675 0.60% 1,698 0.15%
Hypothyroidism 11,125 1.00% 67,968 5.90% Treated constipation 2,484 0.22% 4,729 0.41%
Malignancies 35,543 3.20% 34,429 2.99% Disorders of the immune system 2,754 0.25% 3,980 0.35%
Low back pain 23,777 2.14% 41,352 3.59% Migraine 1,055 0.09% 5,120 0.44%
Asthma (currently treated) 30,161 2.71% 33,709 2.93% Developmental disorder 3,750 0.34% 2,272 0.20%
Glaucoma 24,827 2.23% 33,274 2.89% Chronic sinusitis 2,518 0.23% 3,369 0.29%
Osteoporosis 3,019 0.27% 53,283 4.63% Hematologic chronic disorders 2,598 0.23% 3,140 0.27%
Atrial fibrillation 27,818 2.50% 22,860 1.98% Psoriasis or eczema 2,944 0.26% 2,060 0.18%
Emphysema, chronic bronchitis, COPD 33,653 3.03% 16,643 1.45% Bronchiectasis 2,137 0.19% 2,863 0.25%
Peripheral neuropathy, neuritis 15,561 1.40% 32,028 2.78% Other psycho-active substance misuse 3,791 0.34% 855 0.07%
Ischemic heart disease 32,402 2.92% 13,680 1.19% Attention deficit disorder 2,555 0.23% 844 0.07%
Chronic heart disease, others 26,611 2.40% 18,637 1.62% HIV, AIDS 1,796 0.16% 839 0.07%
Cerebro-vascular disease 22,682 2.04% 22,268 1.93% Transplant status 1,364 0.12% 764 0.07%
Prostatic hypertrophy 43,403 3.91% --- --- Multiple sclerosis 628 0.06% 1,308 0.11%
Deafness, hearing loss 20,264 1.82% 20,518 1.78% Anorexia or bulimia 109 0.01% 1,377 0.12%
Dementia 12,308 1.11% 25,141 2.18%
Blindness & low vision 13,864 1.25% 17,118 1.49% Multimorbidity (2+ conditions) 235,617 21.21% 298,640 25.93%
Chronic kidney disease 13,449 1.21% 12,242 1.06%

Orueta et al.

Orueta et al. BMC Public Health 2013 13:870   doi:10.1186/1471-2458-13-870

Open Data